Latest News

European Investment Bank (EIB) backs Minesto in developing an investment case for the EU's first Tidal Energy Dragon Farm

GOTHENBURG, Sweden, Jan. 27, 2026 /PRNewswire/ -- Minesto, leading ocean energy developer, has on a complementary basis been selected for in-depth investment advisory support by the European Investment Bank (EIB) under the PDA (Project Development Assistance) programme. The program offers extensi...

2026-01-27 22:53 7453

Antigravity Updates A1 with Virtual Flight Simulator and Announces 15% Off US Sale

The world's first 8K 360 drone expands US retail availability to Amazon following breakout success at CES. LOS ANGELES, Jan. 27, 2026 /PRNewswire/ -- Antigravity will announce a major feature update for the Antigravity A1, introducing a built-in Flight Simulator to help new pilots master the ski...

2026-01-27 22:00 6866

Aurzen Super Bowl Projector Deals: Big-Screen Viewing for Less

IRVINE, Calif., Jan. 27, 2026 /PRNewswire/ -- Aurzen launched Super Bowl Projector Deals for viewers who want a big-screen experience without paying TV-sized prices, offering a more flexible and affordable alternative, backed by verified specs based on real-world testing. Super Bowl has become o...

2026-01-27 22:00 6667

FutureMain Bolsters Global Industrial AI Competitiveness with NPU-Based Time-Series AI Project

SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- FutureMain Co., Ltd. , a specialized industrial AI company focused on equipment diagnostics and predictive maintenance, announced that it is playing a pivotal role in a next-generation intelligent semiconductor R&D proj...

2026-01-27 22:00 3763

Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies

CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center...

2026-01-27 22:00 8171

Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0

BOSTON and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, today announced a translational preclinical strategy,HKEY-AIRxTM1.0  designed to address one of the most persistent problems facing biotech leadership: w...

2026-01-27 22:00 5997

NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Billion in Credit Provided to Its Users

NEW YORK, Jan. 27, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Bi...

2026-01-27 21:55 10978

Combatting the Energy Crisis: Eworld Showcases Low-Energy Glass Processing Machinery and Sustainable Solutions at Major Global Expos

International trade shows highlight Eworld's energy-efficient glass processing technologies for architectural and industrial applications JINAN, China, Jan. 27, 2026 /PRNewswire/ -- High energy costs and tightening environmental regulations are no longer just future concerns; they are the immedi...

2026-01-27 21:47 6175

Tineco Elevates Modern Living With a Smarter, More Balanced Floor Care Portfolio

SEATTLE, Jan. 27, 2026 /PRNewswire/ -- As modern homes continue to evolve, consumers are increasingly seeking appliances that combine performance, thoughtful design, and long-term value.Tineco , a leader in intelligent floor care solutions, brings this philosophy to life ...

2026-01-27 21:46 6307

Beetles Gel Polish Celebrates 5-Star Women's Basketball Recruit Jerzy Robinson's College Commitment

Top ranked women's basketball recruit Jerzy Robinson marks a defining life chapter through self-expression with Beetles Gel Polish. NEW YORK, Jan. 27, 2026 /PRNewswire/ -- As young athletes navigate high-pressure moments both on and off the court, Beetles Gel Polish reinforces its long-standing ...

2026-01-27 21:32 6565

Home Control Signs Memorandum of Understanding with NTU Singapore to Explore AIoT Home Healthcare Ecosystem

HONG KONG, Jan. 27, 2026 /PRNewswire/ -- Home Control International Limited (" Home Control" or the "Company", together with its subsidiaries, the "Group"; Stock Code: 1747.HK) is pleased to announce that it has entered into a Strategic Memorandum of Understanding (MoU) with Nanyang Technological ...

2026-01-27 21:25 7169

AGCO Foundation Partners with the University of Sydney to Boost Resilience in Rural Communities

The AU$150,000 partnership will create a dedicated agriculture program for the university. DULUTH, Ga., Jan. 28, 2026 /PRNewswire/ -- AGCO Foundation, a private foundation working to transform lives in farming communities, announced a new partnership with the University of Sydney Business School...

2026-01-27 21:15 6072

RegASK Achieves ISO 27701 Privacy Certification, Strengthening Verifiable Trust in the AI Era

Agentic AI regulatory intelligence leader strengthens its enterprise privacy and governance framework. NEW YORK and SINGAPORE, Jan. 27, 2026 /PRNewswire/ -- As enterprises increasingly rely on AI to navigate the complex global regulatory landscape, the need for verifiable proof of security, priv...

2026-01-27 21:00 5210

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural history expected worsening of cUHDRS in symptomatic patients of -0.73 points over nine months, based on propensity score weighting. Skyhawk also ann...

2026-01-27 21:00 6964

Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....

2026-01-27 21:00 8625

Xi'an Kicks Off 2026 Chang'an Lantern Festival with Epic Light Spectacles to Spring

XI'AN, China, Jan. 27, 2026 /PRNewswire/ -- Recently, the opening lighting ceremony of the 2026 Chang'an Lantern Festival, themed "Thousands of Lanterns Shining on Chang'an and Welcoming Spring with Horses," was grandly held in historic city of Xi'an, China.

2026-01-27 19:40 4746

From creation to product promotion, they are using AIGC's CreatOK video technology to reap dividends in bulk

BEIJING, Jan. 26, 2026 /PRNewswire/ -- Nowadays, the majority of users are no longer unfamiliar with AI text-to-video technology. On various social media platforms, creative videos using AI technology, such as dancing kittens, "AI Shelter", and "AI comic-style selfies", have long been commonplace...

2026-01-27 19:31 4573

University of Chicago Hong Kong Campus Expands 2026 Summer Academy with New Programs

Enhanced Summer Academy to Empower Next Generation of Talent HONG KONG, Jan. 27, 2026 /PRNewswire/ -- The University of Chicago Hong Kong Campus announced the expansion of its 2026 Summer Academy

2026-01-27 19:11 6642

From Guidebooks to Personal Stories, Shanghai Rethinks the Visitor Experience

SHANGHAI, Jan. 27, 2026 /PRNewswire/ -- For decades, visiting Shanghai meant following a familiar set of stops: the Bund at sunset, a stroll through Yuyuan Garden, perhaps a first glimpse of the skyline from Pudong. Increasingly, though, the city wants travelers to move beyond the checklist — and...

2026-01-27 18:46 7850

Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

* Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease. * License and collaboration agreement strengthen Boehringer's inflammatory disease pipeline with a potential, first-in-class, pre-clinical asset. *...

2026-01-27 18:40 6121